Compare Sanofi SA (SNY) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Suncor Energy Inc. — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Suncor Energy Inc. trades at $63.68 (market cap $72.86B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | SU | |
|---|---|---|
Market Cap | $104.83B | $72.86B |
Sector | Health | Energy |
52-Week High | $52.34 | $69.73 |
52-Week Low | $41.33 | $38.17 |
Enterprise Value | $121.32B | $80.99B |
Dividend Yield | 5.5% | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNY trades at $43.76, down 2.02% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 results pending. Revenue grew to $46.72B in 2025, with net income margin improving to 16.72%. Recent positive developments include FDA approval for Sarclisa's wearable injector and EU approval for Cenrifki in multiple sclerosis.
Outlook remains positive with analyst consensus leaning toward buy/hold, though regulatory scrutiny in the EU presents near-term risk. The stock offers a solid dividend yield with the upcoming $2.42 payment. Valuation metrics like P/E of 19.5 and P/B of 1.27 suggest reasonable pricing relative to peers, supported by robust cash flow from operations of $10.75B.
Suncor Energy (SU) trades at $63.70, up 2.03% today, with a bullish technical signal from moving averages. The company reported mixed Q1 2026 earnings, missing EPS estimates, but beat in the prior two quarters. Valuation ratios appear reasonable with a P/E of 16.8 and EV/EBITDA of 7.08. Strong profitability is evident with a net income margin of 11.62% and ROE of 13.97%. A dividend of $0.60 per share is scheduled for payment on June 25, 2026.
The outlook for SU is supported by record production and integrated operations, but faces risks from oil price volatility and operational incidents. Analyst consensus is strongly bullish with 74% buy ratings. The stock's performance hinges on upcoming Q2 2026 results and broader energy market trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
